Electroconvulsive therapy is an effective treatment for severe and medication-resistant depression. There have been no reports describing how a volatile anaesthetic affects haemodynamic responses, seizure duration, and recovery characteristics during electroconvulsive therapy. We carried out a repeated-measure crossover study to compare the effects on haemodynamic responses, seizure duration, and recovery characteristics of the following types of anaesthesia in electroconvulsive therapy: propofol alone, sevoflurane alone, and propofol combined with sevoflurane.
Electroconvulsive therapy (ECT) is an effective treatment for severe and medication-resistant depression and mania, as well as in the treatment of schizophrenic patients with affective disorders, suicidal drive, delusional symptoms, vegetative dysregulation, inanition, and catatonic symptoms 1 . Many intravenous anaesthetics have been used for ECT, including etomidate 2,3 , methohexitone 4-10 , thiamylal 4 , thiopentone 4, 11, 12 , midazolam 13 , diazepam 14 , a combination of methohexitone and alfentanil 15 , and propofol [5] [6] [7] [8] [9] [10] 16, 17 . The long-term, routine use of methohexitone as a hypnotic agent in ECT has been challenged by the introduction of propofol 18 . Because the treatment time is very short, anaesthetic drugs with a rapid recovery profile may be advantageous, and propofol has therefore become widely used for anaesthesia during ECT [5] [6] [7] [8] [9] [10] 16, 17 . However, there have been no reports comparing the effects of volatile anaesthetics on haemodynamic responses, seizure duration and recovery characteristics in patients. The present study was designed to compare the effects on haemo-dynamic responses, seizure duration, and recovery characteristics of three methods of anaesthesia: propofol alone, sevoflurane alone, and propofol combined with sevoflurane. This study was conducted by a repeated-measure crossover design in which each patient served as his or her own control. We chose sevoflurane as a volatile anaesthetic because it is less pungent than many volatile anaesthetics 19 , and induction of anaesthesia with sevoflurane is rapid 20 .
METHODS
After approval was granted from the institutional review board and written informed consent was obtained from patients, 54 ASA physical status 2 or 3 patients undergoing ECT treatments for chronic depression were enrolled in our study. No patient with unstable cardiovascular disease, second or third degree atrioventricular block, arrhythmia, hypotension, sinus bradycardia, chronic obstructive pulmonary disease, renal or hepatic failure, or using beta-adrenergic or calcium-channel blocking drugs was included in the study. Each study patient received one of three different forms of anaesthesia: propofol alone (condition P), sevoflurane alone (condition S), and propofol combined with sevoflurane anaesthesia (condition PS), which were administered on three different days 48 hours apart to allow for washout. The order of each patient's exposure to the different anaesthetics was randomized by a computergenerated program.
Mean arterial blood pressure (MAP), heart rate (HR), oxygen saturation (SpO 2 ) values and an electrocardiogram (ECG) were recorded before anaesthesia induction (baseline). Tonometory blood pressure was measured with a continuous noninvasive blood pressure-monitoring instrument (BP-508, Colin Corporation, Komaki, Japan) 21 . Before administration of succinylcholine, a tourniquet was applied to the patient's upper arm and inflated to isolate circulation to the arm and permit accurate assessment of the motor seizures. No patient was premedicated. For safety, all patients were preoxygenated with 100% oxygen at a flow rate of 8 l/min for five minutes via facemask prior to anaesthesia induction. Under condition P and PS, unconsciousness was induced with propofol 1.5 mg/kg IV, and in the condition S, it was induced with sevoflurane using vital capacity rapid inhalation induction (VCRII) [22] [23] [24] . The VCRII method was carried out as follows: first, the patients were preoxygenated with 100% oxygen at a flow rate of 8 l/min for five minutes via facemask using a Jackson-Rees breathing circuit. Induction was started with a full 4-litre reservoir bag to allow for inspiration of a full vital capacity breath. A mixture of 5% sevoflurane and oxygen was delivered by vaporizer (Sevotec 5, Ohmeda, Madison, WI, U.S.A.) into the circle system of an anaesthesia machine (Modulus® CD, Ohmeda, Madison, WI, U.S.A.). The pop-off valve was kept open at all times. Respiratory gases were sampled into the multi-gas monitor (BP-508, Colin Corporation, Komaki, Japan). Following preoxygenation, the patients were instructed to breathe out to residual volume and hold their breath at residual volume while the circuit was replaced with the preprimed circle system. They were then instructed to take a vital capacity breath and attempt to hold this breath as long as possible, preferably until loss of consciousness ensued. Following initial vital capacity breathing, patients were allowed to resume spontaneous respiration. Loss of consciousness was defined as the loss of both the eyelid reflex and the response to the verbal command, "Open your eyes."
When patients lost consciousness, a blood pressure cuff was applied to isolate circulation to the arm to assess the duration of motor seizure activity. Succinylcholine 1.5 mg/kg IV was then administered, and ventilation was assisted via facemask (oxygen in condition P, and 5% sevoflurane and oxygen in conditions S and PS). In condition PS, a mixture of 5% sevoflurane and oxygen was delivered in advance into the circle system of the anaesthesia machine by vaporizer. Electrical stimulus was delivered via bitemporal electrodes with a SAKAI CS-1 apparatus (Sakai Medical Instruments, Tokyo, Japan) at a 110-volt setting for 7 seconds. The magnitude of the electrical stimulus was maintained at a constant level during the three ECT treatments performed on each patient. Electroencephalographic seizure length was recorded by a two-channel electroencephalograph after the electrical stimulus. These procedures were recently described in part 25, 26 .
Within-group differences in HR and MAP were analysed by paired t-test with Bonferroni's correction. Between-group differences in HR, MAP, and recovery time were analysed by one-way ANOVA followed by the Tukey-Kramer post hoc test for multiple comparisons. Between-group differences in motor and EEG seizure duration time were analysed by the Kruskal-Wallis test followed by Dunn's multiple comparisons test as a post hoc test. A P value of less than 0.05 was considered statistically significant.
RESULTS
Four of the 54 enrolled patients were excluded because they failed to convulse during the first two sessions and required theophylline or caffeine to facilitate seizures. The remaining 50 patients who completed the study (a total of 150 ECT treatments) had an average (mean (SD)) age of 57 (17) y (range 22-80 y), weight of 53 (11) kg (range 33-79 kg), and height of 158 (11) cm (range 147-181 cm); the male: female ratio was 13:37.
Haemodynamic values, duration of seizure activity, and recovery times after ECT under the three anaesthesia conditions are shown in Table 1 . Baseline HR and MAP values were similar in the three conditions. Peak HR after ECT was highest in condition S (Table  1) . Peak MAP after ECT was highest in condition S, and second-highest in condition P ( Table 1) . Recovery time, measured by spontaneous respiration, eye-opening, and ability to follow commands, was longest in condition PS (Table 1) .
Seizure duration results are expressed as median (range). Motor seizure duration in condition P was 30 (10-56) s, in condition S was 16 (0-60) s, and in condition PS was 13 (0-36) s. EEG seizure duration in condition P was 43.5 (16-81) s, in condition S was 26 (0-75) s and in condition PS was 19.5 (0-57) s. Motor seizure duration was significantly less in condition PS than in either condition P (P<0.001) or condition S (P<0.01) ( Figure 1 ). Motor seizure duration was significantly less in condition S than in condition P (P<0.01) ( Figure 1 ). EEG seizure duration was significantly less in condition PS than in condition P (P<0.001), and significantly less in condition S than in condition P (P<0.01) ( Figure 2 ).
End-tidal sevoflurane concentration immediately before the electrical stimulus was delivered was 3.5±0.2% in condition S and 3.4±0.2% in condition PS (difference not significant). Values are mean (SD). HR=heart rate. SCC=succinylcholine. MAP=mean arterial pressure. *P <0.05 versus baseline. **P <0.01 versus baseline. ***P <0.001 versus baseline. ****P <0.0001 versus baseline. †P <0.05 versus sevoflurane. † †P <0.05 versus propofol and sevoflurane. † † †P <0.01 versus propofol and sevoflurane. §P <0.05 versus propofol and sevoflurane. § §P <0.01 versus propofol and sevoflurane. 
DISCUSSION
In our study, peak MAP and HR after ECT were highest with sevoflurane anaesthesia alone. Thus, sevoflurane anaesthesia alone (volatile induction and maintenance of anaesthesia) is most disadvantageous in terms of haemodynamics. As expected, peak MAP was lowest after ECT with the combination propofol and sevoflurane anaesthesia. However, this combination anaesthesia was most disadvantageous in terms of seizure duration, and propofol alone was most advantageous. Recovery time was longest with the combination propofol and sevoflurane anaesthesia because this combination may produce the deepest state of anaesthesia. We conclude that sevoflurane should rarely be used as an alternative anaesthetic induction agent for ECT. Only when venous access is difficult because of dehydration, agitation, confusion, or patients' intolerance to venipuncture would we select volatile induction and maintenance of anaesthesia with sevoflurane for ECT. Routine anaesthesia with sevoflurane alone volatile induction and maintenance is not recommended because it provides no advantage in terms of haemodynamics or seizure duration in ECT treatment.
Although the ultrashort-acting barbiturate methohexitone is widely used as the anaesthetic agent of choice for ECT, propofol is now considered an alternative 27 because it is associated with a smaller haemodynamic response during ECT 3,5,7,12 . Abrams 27 formerly recommended against using propofol for ECT because of its systematic seizure-shortening effects 5, 7, 11, 28 , a conclusion reached by others as well 29 . Since then, however, studies have shown that the reduced seizure duration obtained with propofol is not associated with a reduced therapeutic effect in comparison to that of methohexitone anaesthesia 6, 8, 16, 30 . This agent should be considered for ECT anaesthesia in patients who have problematic pre-existing hypertension during ECT 28 .
There have been many reports on intravenous anaesthetic agents for ECT, and Tanaka and colleagues 31 compared thiopentone alone, thiopentone combined with sevoflurane (1MAC) and nitrous oxide, and thiopentone combined with sevoflurane (2MAC) and nitrous oxide as anaesthetic agents for ECT (they investigated only effects on haemodynamics). However, none have described how volatile anaesthetics affect seizure duration, haemodynamic responses, and recovery characteristics. Thus, the present study was designed to compare the effects on haemodynamic responses, seizure duration, and recovery characteristics of the three methods of anaesthesia: propofol alone, sevoflurane alone, and propofol combined with sevoflurane. We tried the combination of sevoflurane and propofol anaesthesia as well as sevoflurane anaesthesia alone in anticipation of a further reduction of blood pressure.
The limitation of this study is that the depth of anaesthesia, especially in conditions P and S, may not have been equal. Moreover, the mechanism of the seizure-shortening effects of sevoflurane remains unclear. Further investigation is needed.
In conclusion, sevoflurane anaesthesia alone is most disadvantageous in terms of haemodynamics. Propofol-sevoflurane anaesthesia is advantageous in terms of haemodynamics but disadvantageous in terms of seizure duration and recovery time. Propofol alone is most advantageous in terms of seizure duration. We should choose anaesthetics for ECT on a case-by-case basis. 
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